Spears Abacus Advisors LLC Laboratory Corp Of America Holdings Transaction History

Spears Abacus Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$209.01 - $232.56 $70.6 Million - $78.6 Million	337,821 Added 6689.52%	342,871 $74.9 Million
Q2 2023 Aug 14, 2023	BUY	$211.93 - $241.33 $877,390 - $999,106	4,140 Added 454.95%	5,050 $1.22 Million
Q4 2022 Feb 13, 2023	BUY	$203.72 - $248.97 $185,385 - $226,562	910 New	910 $214,000
Q3 2021 Nov 15, 2021	SELL	$274.82 - $308.34 $16,764 - $18,808	-61 Reduced 6.28%	910 $256,000
Q2 2021 Aug 09, 2021	SELL	$251.87 - $278.14 $75,561 - $83,442	-300 Reduced 23.6%	971 $268,000
Q3 2020 Nov 16, 2020	SELL	$167.03 - $201.3 $501 - $603	-3 Reduced 0.24%	1,271 $239,000
Q2 2020 Aug 12, 2020	BUY	$113.31 - $182.44 $144,356 - $232,428	1,274 New	1,274 $212,000

128

2.48M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $19.9B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Spears Abacus Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Spears Abacus Advisors LLC with notifications on news.